Home › Kanser sa Ovary › Montana › Billings
Pag-aaral pangklinika para sa Kanser sa Ovary sa Billings, MT
9 pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Billings (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Billings Clinic Cancer Center, Billings
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Nagre-recruitPhase 3
- Research Site, Billings
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Nagre-recruitPhase 2
- Intermountain Health - Intermountain Health West End Clinic /ID# 278470, Billings
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Nagre-recruitPhase 3
- Billings Clinic, Billings
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Nagre-recruitPhase 2
- St. Vincent Regional Hospital - West End Clinic, Billings
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Nagre-recruit
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- Saint Vincent Frontier Cancer Center, Billings
- at 1 pa
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Nagre-recruitPhase 3
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- Saint Vincent Frontier Cancer Center, Billings
- at 1 pa
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Nagre-recruitPhase 3
- St. Vincent Gynecologic Oncology, Billings
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Billings
Pag-aaral para sa Kanser sa Ovary sa ibang lungsod
- Houston, TX89 pag-aaral
- New York City, NY69 pag-aaral
- Boston, MA61 pag-aaral
- Los Angeles, CA50 pag-aaral
- Nashville, TN49 pag-aaral
- Arlington, VA46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Columbus, OH39 pag-aaral
- St. Louis, MO38 pag-aaral
- Chicago, IL36 pag-aaral
- San Antonio, TX31 pag-aaral
- Cleveland, OH30 pag-aaral
Iba pang pag-aaral sa Billings
- Non-Small Cell Lung Cancer17 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Kanser sa Baga13 pag-aaral
- Kanser sa Suso10 pag-aaral
- Melanoma7 pag-aaral
- Chronic Lymphocytic Leukemia7 pag-aaral
- Acute Myeloid Leukemia7 pag-aaral
- Kanser sa Pantog6 pag-aaral
- Colon Cancer6 pag-aaral
- Colorectal Cancer6 pag-aaral
- Rectal Cancer5 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg4 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.